MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cardiovascular Systems, Inc. - Common Stock (NQ:CSII)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cardiovascular Systems, Inc. - Common Stock

< Previous 1 2 Next >
Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical Trial
From Cardiovascular Systems, Inc.
Via Business Wire
CARDIOVASCULAR SYSTEMS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cardiovascular Systems, Inc. - CSII
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)
From Brodsky & Smith LLC
Via GlobeNewswire
CARDIOVASCULAR SYSTEMS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cardiovascular Systems, Inc. - CSII
From Kahn Swick & Foti, LLC
Via Business Wire
Cardiovascular Systems (NASDAQ: CSII) Enters Into Agreement to be Acquired By Abbott Labs (NYSE: ABT) For $890 Million
Cardiovascular Systems, Inc. (NASDAQ: CSII) is engaged as a medical device company, which is focused on the research, development and 
Via Spotlight Growth
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)
From Brodsky & Smith LLC
Via GlobeNewswire
CSII STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Cardiovascular Systems, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2023 Second Quarter Financial Results
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Host Earnings Conference Call on February 9, 2023
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.’s Thrombectomy System
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Participate in Two November Healthcare Conferences
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2023 First Quarter Financial Results
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Announces Full Market Release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Host Earnings Conference Call on November 3, 2022
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2022 Third Quarter Financial Results
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Host Earnings Conference Call on May 4, 2022
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Participate at Two Upcoming Healthcare Conferences
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Announces First In-Human Experience With Company’s Propel™ Percutaneous Ventricular Assist Device
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Announces Partnership With Innova Vascular, Inc. to Develop Full Line of Thrombectomy Devices
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2022 Second Quarter Financial Results
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Participate at SVB Leerink 2022 Global Healthcare Conference
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. and OrbusNeich Announce FDA PMA Approval of Scoreflex® Scoring Balloon
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Announces Development of Intravascular Lithotripsy Technology for the Treatment of Coronary and Peripheral Artery Diseases
From Cardiovascular Systems, Inc.
Via Business Wire
CORRECTING and REPLACING Cardiovascular Systems, Inc. to Webcast Fiscal 2022 Second-Quarter Earnings Conference Call Thursday, February 3
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Webcast Fiscal 2022 Second-Quarter Earnings Conference Call Thursday, February 3
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2022 First Quarter Financial Results
From Cardiovascular Systems, Inc.
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story